Skip to main content
. 2020 May 20;20(2):1127–1134. doi: 10.3892/ol.2020.11647

Table I.

Association between PD-L1 expression levels and clinicopathological variables of patients with colorectal cancer.

Variable PD-L1 (+), n (%) PD-L1 (−), n (%) χ2-value P-value
Age, years
  >65 13 (41.9) 59 (39.3) 0.073 0.788
  ≤65 18 (58.1) 91 (60.7)
Sex
  Male 13 (41.9) 86 (57.3) 2.458 0.117
  Female 18 (58.1) 64 (42.7)
Tumor size
  >5 cm 10 (32.3) 92 (61.3) 8.830 0.003
  ≤5 cm 21 (67.7) 58 (38.7)
Tumor classification
  Tubular adenocarcinoma 22 (71.0) 121 (80.7) 4.002 0.135
  Mucinous adenocarcinoma 5 (16.1) 23 (15.3)
  Other 4 (12.9) 6 (4.0)
Vascular and lymphatic infiltration
  No 11 (35.5) 95 (63.3) 8.221 0.004
  Yes 20 (64.5) 55 (36.7)
Perineurium invasion
  No 21 (67.7) 119 (79.3) 1.970 0.160
  Yes 10 (32.3) 31 (20.7)
Tumor location
  Rectum 12 (38.7) 74 (49.3) 1.163 0.281
  Colon 19 (61.3) 76 (50.7)
Tumor differentiation
  Medium and high differentiation 13 (41.9) 134 (89.3) 37.831 <0.001
  Poorly differentiated 18 (58.1) 16 (10.7)
Tumor-node-metastasis stage
  I–II 11 (35.5) 85 (56.7) 4.628 0.031
  III 20 (64.5) 65 (43.3)

PD-L1, programmed death ligand 1.